Rhoclone 300mcg Injection
Rhoclone 300mcg Injection is an anti-D (Rh) immunoglobulin used to prevent Rh incompatibility (Rhesus disease) in RhD-negative individuals, especially pregnant women carrying RhD-positive babies or patients who have received mismatched blood transfusions. It works by neutralizing RhD-positive antigens that may have entered the bloodstream, preventing the immune system from producing antibodies against them.
Contact us for sales assistance from our Biomedical Engineer.
Features:
-
Contains Anti-D (Rh) Immunoglobulin, derived from human plasma
-
Prevents isoimmunisation in RhD-negative mothers
-
Useful in managing complicated pregnancies involving Rh incompatibility
-
Administered only by healthcare professionals
-
Standard dose: 300 mcg (1500 IU) – effective for exposure to up to 15 ml of fetal red blood cells
-
Used for both antenatal and postnatal prophylaxis
| Technical Specification |
|
|---|
-
1 ml per vial
-
Prevents hemolytic disease of the newborn (HDN)
-
Helps avoid complications in current and future pregnancies
-
Ensures immune tolerance in RhD-negative patients exposed to RhD-positive blood
-
Clinically proven with high safety profile under supervision
-
Single-dose efficacy in most standard exposures
-
Minimal side effects, mostly local and temporary
